Immune Response in Dialysis Patients Vaccinated Against COVID-19
NCT04805632 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2024-04-18
Summary
This is a prospective cohort study aimed to evaluate short- and mid-term immune response after SARS-CoV-2 vaccination using Gam-COVID-Vac (Sputnik V) vaccine in dialysis patients compared to the control group (medical staff).
Conditions
- Covid19
- Chronic Kidney Disease 5D
Sponsors & Collaborators
-
Saint Petersburg State University, Russia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-23
- Primary Completion
- 2022-01-30
- Completion
- 2022-01-30
Countries
- Russia
Study Locations
More Related Trials
-
Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition)
NCT06068556 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Manufacturing Lot of StaphVAX
NCT00211900 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19
NCT04436471 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19
NCT04437875 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19
NCT04530396 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Drug
NCT06834100 ·Status: RECRUITING ·Phase: PHASE3
-
Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19
NCT05083039 ·Status: COMPLETED
-
Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity
NCT05076227 ·Status: COMPLETED
-
Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan
NCT04871841 ·Status: COMPLETED
-
Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older
NCT05726084 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease
NCT00130260 ·Status: TERMINATED ·Phase: PHASE3
-
This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19
NCT05046548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient
NCT03576014 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Gam-COVID-Vac in Adolescents
NCT04954092 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela
NCT04642339 ·Status: UNKNOWN ·Phase: PHASE3
-
An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)
NCT05407142 ·Status: UNKNOWN ·Phase: PHASE3
-
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
NCT03966040 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray
NCT05248373 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE
NCT04656613 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Safety and Immunogenicity of BVRS-GamVac-Combi
NCT04128059 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults
NCT04866069 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection
NCT04640233 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19
NCT05097053 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years
NCT04895982 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.
NCT05156723 ·Status: COMPLETED ·Phase: PHASE1/PHASE2